Converted from ./060612162515lis.06ct954954cumrep27-00
HOSPITAL AUTHORITY NTWC PATHOLOGY SERVICE CHEMICAL PATHOLOGY LABORATORY Lab No. : 06CT954954
Name : TESTING,LIS TESTING Hospital/OPD No : %C36416B05R3115HKID No : %LAUTH Location : TMH/MED/LISSex/Age : M/5Y Bed :DOB : 11/11/2000 Doctor : UnknownUnit : TMH/MED Doctor Code : TMH/--/UNKRef. :------------------------------------------------------------------------------------------
Collect Date : 12/05/06 02/06/06 Collect Time : --:--
Arrive Date : 12/05/06 02/06/06 Arrive Time : 14:33
Request No. : CT998977 CT954954
----------------------------------------------------------------------------------------- Blood Tacrolimus Tacrolimus (F0) -- 3.3 L See Below ug/L Tacrolimus (F0, -- 3.2 L See Below ug/L LCMS) Tacrolimus (F2, 5.0 -- ug/L LCMS) Tacrolimus (F4, 3.0 -- ug/L LCMS) Tacrolimus (AUC, 45.9 -- h.ug/L LCMS)
-----------------------------------------------------------------------------------------Comment:06CT954954 Signout Comment Test for signout comment. Footnotes:
Tacrolimus (F0) - Reference Range : (12-hr trough) 5 - 20 ug/L (early
post-transplant). Optimal range depends onindividual sensitivity to theimmunosuppressive effects.
- Reference Range : (12-hr trough)5 - 20 ug/L (early
post-transplant). Optimal range depends onindividual sensitivity to theimmunosuppressive effects.
Lab Comment: New category of TFT for pregnant patients is available in GCRS
for ward ordering from 9/2/2006. Ref. intervals (pregnancy) willbe issued accordingly. For request by lab. form, please specify
***** This is a testing report and should not be used for clinical treatment. Please destroy it if found. ***** N.B. Patient Demographic data has been changed as follows:
------------------------------------------------------------------------------------------Report date & time : 16:25 on 12/06/06 Print on 12/06/06 16:25Report Destination : TMH/--/LIS - LIS
HOSPITAL AUTHORITY NTWC PATHOLOGY SERVICE CHEMICAL PATHOLOGY LABORATORY Lab No. : 06CT954954
Name : TESTING,LIS TESTING Hospital/OPD No : %C36416B05R3115HKID No : %LAUTH Location : TMH/MED/LISSex/Age : M/5Y Bed :DOB : 11/11/2000 Doctor : UnknownUnit : TMH/MED Doctor Code : TMH/--/UNKRef. :------------------------------------------------------------------------------------------
for pregnant patient and indicate the trimester.
***** This is a testing report and should not be used for clinical treatment. Please destroy it if found. ***** Authorized by : Wong,Chi Keung ********** End of report **********
Cumulative report for retention in patient's record until succeeding report is available. N.B. Patient Demographic data has been changed as follows:
------------------------------------------------------------------------------------------Report date & time : 16:25 on 12/06/06 Print on 12/06/06 16:25Report Destination : TMH/--/LIS - LIS
2 2012 • Hessisches Ärzteblatt Fortbildung Sicherheitsbedenken und Dosissenkungen für Cipramil® und Cipralex® Citalopram (Cipramil® und weitere Cital o-pram®-Generika), sowie Escitalopram (Cip-maldosis auf 20 mg gesenkt. Für das Iso-ralex®) sind selektive Serotonin-Wiederauf-Rhythmusstörungen, weibliche Patienten, drehende Isomer Escitalopram (Cipralex®) Episoden
Mendis Report FACULTY OF MEDICINE, UNIVERSITY OF GEZIRA Susirith Mendis, Dean Faculty of Medicine University of Ruhuma, Galle, Sri Lanka The Republic of Sudan, situated in northeastern Africa, is the largest country of the African continent. Its total area of 2.5 million sq. km and population of 30 million is divided into 26 states. The economy of Sudan depends mainly on agricultur
HOSPITAL AUTHORITY NTWC PATHOLOGY SERVICE
HOSPITAL AUTHORITY NTWC PATHOLOGY SERVICE